{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:11:41Z","timestamp":1777961501938,"version":"3.51.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pharmaceutical services play a critical role in safeguarding medication safety and optimizing therapeutic outcomes. Their value is increasingly recognized in China, where recent policy reforms have introduced new medical service pricing items, and several provinces have piloted an inpatient consultation fee (clinical pharmacy surcharge), namely inpatient pharmacist consultation (IPC), as a billable services.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study used a discrete choice experiment (DCE) to evaluate hospitalized patients\u2019 preferences for IPC and the factors shaping these choices, providing evidence to inform service development and policy-making.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Study attributes and levels were derived from literature review, patient surveys, and expert interviews. Attributes included hospital tier (tertiary vs. non-tertiary), pharmacist professional title (attending pharmacist, associate chief pharmacist, chief pharmacist), consultation frequency (once, three times, five times per week), duration (5, 10, 15\u202fmin), service outcome (improved efficacy vs. reduced medication errors), and unit cost (10 or 15 CNY per session; 1 CNY\u202f\u2248\u202f0.15 USD). A DCE questionnaire was administered to inpatients across six Sichuan hospitals. Preferences were analyzed using a mixed logit model to estimate regression coefficients (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      ) and willingness-to-pay (WTP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 320 valid responses, patients preferred consultations delivered by associate chief pharmacists (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f0.182,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001; WTP 5.00 CNY) in tertiary hospitals (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f0.138,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001; WTP 3.80 CNY), with a primary focus on reducing medication errors (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f0.125,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.002; WTP 3.42 CNY). Patients favored three sessions per week (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f0.156,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.005; WTP 4.29 CNY) lasting 15\u202fmin each (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f0.133,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.016; WTP 3.65 CNY). Service cost had a limited negative influence on choices (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f\u22120.036,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001) within the narrow price range of 10 to 15 CNY tested in this study. The optimal profile (associate chief pharmacist, tertiary hospital, three times per week, 15\u202fmin\/session, error reduction focus, 10 CNY\/session) achieved a 68.4% predicted choice probability. Subgroup analyses showed that low-income patients prioritized consultation frequency, urban patients preferred longer duration, and patients with chronic diseases emphasized efficacy over error reduction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Inpatients demonstrated clear preferences for attributes of IPC, with variations by income, residence, and chronic disease status. Greater involvement of clinical pharmacists, tailored adjustment of consultation frequency and duration, and integration into hierarchical diagnosis and treatment and chronic disease management were encouraged. Price has limited influence on choices. We recommend including pharmaceutical consultations in health insurance reimbursement after pilot programs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1809396","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:31:51Z","timestamp":1777959111000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Quantifying patient preferences for inpatient pharmacist consultation: a multi-center discrete choice experiment in Sichuan, China"],"prefix":"10.3389","volume":"14","author":[{"given":"Guirong","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, West China Hospital, Sichuan University","place":["Chengdu, Sichuan, China"]},{"name":"Department of Pharmacy, Chengdu Shangjin Nanfu Hospital","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Xiao","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyuan","family":"Liu","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hospital of Chengdu University of Traditional Chinese Medicine","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[{"name":"West China School of Pharmacy, Sichuan University","place":["Chengdu, Sichuan, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1439145","DOI":"10.3389\/fphar.2024.1439145","article-title":"The roles and patterns of critical care pharmacists: a literature review and practical operation model in China","volume":"15","author":"Wei","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1583818","DOI":"10.3389\/fphar.2025.1583818","article-title":"Retrospective evaluation of resident pharmacists' services in a liver intensive care unit: a single-center experience","volume":"16","author":"Meng","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e70025","DOI":"10.1002\/jia2.70025","article-title":"Preferences for HIV pre-exposure prophylaxis among men who have sex with men and trans women in 15 countries and territories in Asia and Australia: a discrete choice experiment","volume":"28","author":"Tieosapjaroen","year":"2025","journal-title":"J Int AIDS Soc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"105420","DOI":"10.1016\/j.healthpol.2025.105420","article-title":"What matters most to the population in case of chronic conditions? Results from a discrete choice experiment in Italy","volume":"161","author":"Vainieri","year":"2025","journal-title":"Health Policy"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s13300-025-01779-8","article-title":"Quantifying patient preferences for basal insulin treatments in adults living with type 2 diabetes: a discrete choice experiment in Canada, Spain, France, and Japan","volume":"16","author":"Jones","year":"2025","journal-title":"Diabetes Ther"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1384667","DOI":"10.3389\/fphar.2024.1384667","article-title":"Estimating preferences and willingness to pay for pharmacogenetic testing in populations who are medically underserved: a discrete choice experiment","volume":"15","author":"Gawronski","year":"2024","journal-title":"Front Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s40273-017-0506-4","article-title":"Discrete choice experiments: a guide to model specification, estimation and software","volume":"35","author":"Lancsar","year":"2017","journal-title":"PharmacoEconomics"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s40273-025-01495-y","article-title":"The evolving landscape of discrete choice experiments in health economics: a systematic review","volume":"43","author":"Nouwens","year":"2025","journal-title":"PharmacoEconomics"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0191-2615(02)00046-2","article-title":"A latent class model for discrete choice analysis: contrasts with mixed logit","volume":"37","author":"Greene","year":"2003","journal-title":"Transp Res Pt B-Methodol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/1099-1255(200009\/10)15:5<447::AID-JAE570>3.0.CO;2-1","article-title":"Mixed MNL models for discrete response","volume":"15","author":"McFadden","year":"2000","journal-title":"J Appl Econ"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1022558715350","article-title":"The mixed logit model: the state of practice","volume":"30","author":"Hensher","year":"2003","journal-title":"Transportation"},{"key":"ref12","volume-title":"Discrete Choice Methods with Simulation","author":"Train","year":"2009"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/s12913-017-2433-7","article-title":"Patients' preferences for primary health care - a systematic literature review of discrete choice experiments","volume":"17","author":"Kleij","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"597389","DOI":"10.3389\/fpubh.2020.597389","article-title":"Patient preferences for specialty pharmacy services: a stated preference discrete-choice experiment in China","volume":"8","author":"Hu","year":"2020","journal-title":"Front Public Health"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1093\/ibd\/izae015","article-title":"Patient preferences for treatment attributes in inflammatory bowel disease: results from a large survey across seven European countries using a discrete choice experiment","volume":"30","author":"Fiorino","year":"2024","journal-title":"Inflamm Bowel Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s40271-023-00652-9","article-title":"Patient preferences for pharmacy services: a systematic review of studies based on discrete choice experiments","volume":"17","author":"Riboulet","year":"2024","journal-title":"Patient"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7447","DOI":"10.1007\/s00520-022-07154-8","article-title":"Preferences for oral nutritional supplement therapy among postoperative patients with gastric cancer: a discrete choice experiment","volume":"30","author":"Wang","year":"2022","journal-title":"Support Care Cancer"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s40271-015-0118-z","article-title":"Sample size requirements for discrete-choice experiments in healthcare: a practical guide","volume":"8","author":"de Bekker-Grob","year":"2015","journal-title":"Patient"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","article-title":"Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR conjoint analysis good research practices task force","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/hec.984","article-title":"Effects coding in discrete choice experiments","volume":"14","author":"Bech","year":"2005","journal-title":"Health Econ"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11116-011-9331-3","article-title":"Assuring finite moments for willingness to pay in random coefficient models","volume":"39","author":"Daly","year":"2012","journal-title":"Transportation"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/hec.1197","article-title":"A comparison of approaches to estimating confidence intervals for willingness to pay measures","volume":"16","author":"Hole","year":"2007","journal-title":"Health Econ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1080\/00325481.2026.2641856","article-title":"Patient medication preferences in follicular lymphoma in the United States: a discrete choice experiment","volume":"138","author":"Gaballa","year":"2026","journal-title":"Postgrad Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"105408","DOI":"10.1016\/j.ijnurstu.2026.105408","article-title":"Preferences for palliative care services for patients with advanced cancer from the demand-supply perspective: a multicenter discrete choice experiment","volume":"179","author":"Tang","year":"2026","journal-title":"Int J Nurs Stud"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"100969","DOI":"10.1016\/j.imr.2023.100969","article-title":"Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: a discrete choice experiment study","volume":"12","author":"Teng","year":"2023","journal-title":"Integr Med Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13690-025-01643-y","article-title":"Preferences for group psychological interventions on perinatal depression in China: a discrete choice experiment","volume":"83","author":"Wu","year":"2025","journal-title":"Arch Public Health"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e057280","DOI":"10.1136\/bmjopen-2021-057280","article-title":"Patient preferences and attitudes towards first choice medical services in Shenzhen, China: a cross-sectional study","volume":"12","author":"Zhao","year":"2022","journal-title":"BMJ Open"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1510311","DOI":"10.3389\/fpubh.2025.1510311","article-title":"The analysis of factors influencing patient choice of healthcare providers between tertiary hospitals and community clinics","volume":"13","author":"Wu","year":"2025","journal-title":"Front Public Health"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/S0140-6736(14)60075-1","article-title":"An assessment of progress towards universal health coverage in Brazil, Russia, India, China, and South Africa (BRICS)","volume":"384","author":"Marten","year":"2014","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e0188354","DOI":"10.1371\/journal.pone.0188354","article-title":"A national survey of clinical pharmacy services in county hospitals in China","volume":"12","author":"Yao","year":"2017","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.sapharm.2013.08.006","article-title":"Pharmacist services provided in general practice clinics: a systematic review and meta-analysis","volume":"10","author":"Tan","year":"2014","journal-title":"Res Social Adm Pharm"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s11096-015-0137-9","article-title":"Effectiveness of clinical pharmacy services: an overview of systematic reviews (2000\u20132010)","volume":"37","author":"Rotta","year":"2015","journal-title":"Int J Clin Pharm"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1543-5946(04)90002-5","article-title":"Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults?","volume":"2","author":"Hanlon","year":"2004","journal-title":"Am J Geriatr Pharmacother"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1809396\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:31:52Z","timestamp":1777959112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1809396\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":33,"alternative-id":["10.3389\/fpubh.2026.1809396"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1809396","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"article-number":"1809396"}}